JERUSALEM, Jan. 7, 2025 /PRNewswire/ — Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed funding round led by Lightspeed Venture Partners, with participation from I-Next Capital and the Lowy Medical Research…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.